Cargando…
Rab GTPases as Physiological Substrates of LRRK2 Kinase
LRRK2 (Leucine-Rich Repeat Kinase 2) is a gene whose specific mutations cause Parkinson's disease (PD), the most common neurodegenerative movement disorder. LRRK2 harbors GTPase and kinase activities, two enzyme activities that play critical roles in the regulation of cellular signal transducti...
Autores principales: | Seol, Wongi, Nam, Daleum, Son, Ilhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Brain and Neural Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6526114/ https://www.ncbi.nlm.nih.gov/pubmed/31138985 http://dx.doi.org/10.5607/en.2019.28.2.134 |
Ejemplares similares
-
LRRK2 Kinase Inhibitor Rejuvenates Oxidative Stress-Induced Cellular Senescence in Neuronal Cells
por: Ho, Dong Hwan, et al.
Publicado: (2021) -
LRRK2 Inhibition Mitigates the Neuroinflammation Caused by TLR2-Specific α-Synuclein and Alleviates Neuroinflammation-Derived Dopaminergic Neuronal Loss
por: Ho, Dong-Hwan, et al.
Publicado: (2022) -
Analysis of α-synuclein levels related to LRRK2 kinase activity: from substantia nigra to urine of patients with Parkinson’s disease
por: Nam, Daleum, et al.
Publicado: (2021) -
G2385R and I2020T Mutations Increase LRRK2 GTPase Activity
por: Ho, Dong Hwan, et al.
Publicado: (2016) -
Increase in anti-apoptotic molecules, nucleolin, and heat shock protein 70, against upregulated LRRK2 kinase activity
por: Jang, Jihoon, et al.
Publicado: (2018)